Updated NewsHeart Failure Patients With Preserved Ejection Fraction May Benefit From New …Medical News TodayLCZ696, a first-in-class compound, may improve treatment outcomes for half of all patients with heart failure, according to a Phase II clinica…

Depression lowers heart failure survival oddsFood ConsumerSunday Aug 26, 2012 (foodconsumer.org) — The prognosis of heart failure is not too bad compared to heart attack. But the long term survival odds for heart failure patients who also suffer depre…

SUMO1 protein may treat and/or prevent heart failureNews-Medical.netA promising new drug target for the treatment and prevention of heart failure has been discovered by researchers at Mount Sinai School of Medicine in New York, NY, US. The study was pr…

Parachute device improves outcomes in patients with ischemic heart failureNews-Medical.netA novel non-invasive device which separates healthy and damaged heart muscle and restores ventricle function improves 3 year outcomes in patients with ischemic he…

ESC: Copeptin Level in CHF May Predict DeathMedPage TodayHigh levels of the biomarker copeptin, the C-terminal precursor peptide of vasopressin, appear to predict an increased mortality risk for heart failure patients. Point out that even after adjustm…

New Novartis drug shows potential in heart failureReutersMUNICH (Reuters) – An experimental drug from Novartis may help up to half of heart failure patients for whom no effective treatment is available, although the evidence so far is indirect. Results…

New Novartis Phase II data show LCZ696 may provide clinical benefits in …ReutersNovartis International AG / New Novartis Phase II data show LCZ696 may provide clinical benefits in patients with a difficult-to-treat form of heart failure . Processed a…

PARAMOUNT: Dual-action agent shows promise in preserved-EF heart failureTheHeart.OrgIn a randomized comparison of the angiotensin-receptor/neprilysin inhibitor (ARNI) LCZ696 (Novartis) vs the angiotensin-receptor blocker (ARB) valsartan, levels of a he…

Updated NewsNew Novartis drug shows potential in heart failureReuters IndiaMUNICH (Reuters) – An experimental drug from Novartis may help up to half of heart failure patients for whom no effective treatment is available, although the evidence so far is…

New Novartis drug shows potential in heart failure treatmentReutersLCZ696 reduces protein linked to heart failure in study. * Targets type of heart failure where other options lacking. * Novartis aims to revive heart portfolio as Diovan declines. By Be…